Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 14.69.
Forward PE Ratio (14.69) = Close Price ($73.09) / Consensus Forward EPS ($4.92)
FORWARD PE RATIO
14.69
SECTOR MEDIAN · HEALTHCARE
20.31
median of 67 covered companies
CURRENT VS SECTOR MEDIAN
-27.67%
vs the sector median at left
GE HealthCare Technologies Inc.
Market Cap
$33.01B
Forward PE Ratio
14.69
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| GE HealthCare Technologies Inc. (GEHC) | $33.01B | 14.69 |
| Centene Corp. (CNC)vs › | $32.79B | 14.16 |
| ResMed Inc. (RMD)vs › | $32.58B | 20.31 |
| DexCom, Inc. (DXCM)vs › | $34.20B | 34.16 |
| Biogen Inc. (BIIB)vs › | $31.16B | 16.63 |
| Waters Corporation (WAT)vs › | $31.11B | 28.56 |
| Zoetis Inc. (ZTS)vs › | $30.96B | 10.71 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $30.22B | 33.11 |
| Medline Inc. (MDLN)vs › | $29.95B | 23.20 |
| Mettler-Toledo International Inc. (MTD)vs › | $28.80B | 30.54 |
Trailing P/E
20.9
reported TTM EPS
Forward P/E
14.7
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $4.92 implies +42.6% EPS growth vs the reported trailing $3.45.
At today's $73.09 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $4.92 | $4.87 – $4.99 | 12 | 14.9x |
| 2027-12-31 | $5.43 | $5.16 – $5.53 | 12 | 13.5x |
| 2028-12-31 | $6.04 | $5.41 – $6.40 | 8 | 12.1x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
